EVH
Evolent Health, Inc. NYSE Listed Jun 5, 2015$4.27
Mkt Cap $486.9M
52w Low $2.10
21.8% of range
52w High $12.06
50d MA $2.96
200d MA $5.45
P/E (TTM)
-0.7x
EV/EBITDA
-3.6x
P/B
1.0x
Debt/Equity
2.4x
ROE
-103.4%
P/FCF
96.1x
RSI (14)
—
ATR (14)
—
Beta
0.37
50d MA
$2.96
200d MA
$5.45
Avg Volume
3.1M
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
800 North Glebe Road · Arlington, VA 22203 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 3.83 | -4.4% | +11.5% | — | — | — | — | — |
| Feb 24, 2026 | AMC | 0.06 | 0.08 | +33.3% | 2.56 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% | — |
| Nov 6, 2025 | AMC | 0.10 | 0.05 | -50.0% | 6.00 | +3.0% | -17.3% | -0.2% | +1.8% | -11.7% | -6.5% | — |
| Aug 7, 2025 | AMC | 0.09 | -0.10 | -211.1% | 9.69 | -13.4% | -7.1% | +2.4% | -4.6% | +1.9% | -1.7% | — |
| May 8, 2025 | AMC | 0.09 | 0.06 | -33.3% | 10.78 | +3.9% | -16.0% | +2.9% | -0.4% | -3.6% | -1.3% | — |
| Feb 20, 2025 | AMC | 0.38 | -0.02 | -105.3% | 10.71 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% | — |
| Nov 7, 2024 | AMC | 0.30 | 0.04 | -86.7% | 24.57 | -41.4% | -45.6% | +13.2% | -4.6% | -11.7% | -0.6% | — |
| Aug 8, 2024 | AMC | 0.21 | 0.30 | +42.9% | 20.87 | +32.3% | +26.5% | -4.2% | +3.8% | +1.5% | +2.1% | — |
| May 9, 2024 | AMC | 0.21 | 0.34 | +61.9% | 26.96 | -2.7% | -9.3% | -2.9% | +0.4% | -1.3% | -1.0% | — |
| Feb 22, 2024 | AMC | 0.11 | 0.23 | +109.1% | 29.77 | +10.0% | +14.4% | -1.6% | +1.9% | -1.1% | +0.3% | — |
| Nov 2, 2023 | AMC | 0.09 | 0.30 | +233.3% | 24.01 | +6.7% | +13.5% | +3.3% | +1.0% | -1.9% | -0.8% | — |
| Aug 2, 2023 | AMC | 0.09 | 0.14 | +55.6% | 29.63 | -1.8% | -5.1% | +5.9% | -2.6% | -0.4% | -2.4% | — |
| May 3, 2023 | AMC | 0.15 | 0.21 | +40.0% | 35.20 | -9.1% | -4.7% | +1.4% | +2.1% | +1.3% | -0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.25 | $3.17 | -2.5% | +10.2% | -2.0% | +1.1% | -4.2% | -6.8% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 26 | Truist | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 26 | Citigroup | Maintains | Buy → Buy | — | $3.14 | $3.14 | +0.0% | +5.7% | -2.1% | +10.2% | -2.0% | +1.1% |
| Feb 25 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | BTIG | Maintains | Buy → Buy | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 25 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $2.56 | $2.51 | -2.0% | +22.7% | +5.7% | -2.1% | +10.2% | -2.0% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $3.21 | $3.18 | -0.9% | +1.6% | -5.2% | -1.0% | -5.6% | -1.4% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $4.16 | $4.17 | +0.2% | +0.2% | -0.5% | -3.4% | -2.7% | +1.0% |
| Jan 6 | Citizens | Maintains | Market Outperform → Market Outperform | — | $3.95 | $3.93 | -0.5% | +1.8% | +3.2% | +0.2% | +0.2% | -0.5% |
| Nov 21 | Citigroup | Maintains | Buy → Buy | — | $3.69 | $3.67 | -0.5% | +12.2% | +3.1% | +0.9% | -2.6% | +0.0% |
| Nov 17 | JP Morgan | Maintains | Overweight → Overweight | — | $4.18 | $4.10 | -1.9% | -7.4% | +3.4% | -11.5% | +4.2% | +12.2% |
| Nov 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.16 | $4.03 | -3.1% | +0.5% | -7.4% | +3.4% | -11.5% | +4.2% |
| Nov 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $5.04 | $5.05 | +0.2% | -11.7% | -6.5% | +0.5% | -7.4% | +3.4% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $4.96 | $5.01 | +1.0% | -0.2% | +1.8% | -11.7% | -6.5% | +0.5% |
| Nov 10 | Citizens | Maintains | Market Outperform → Market Outperform | — | $4.96 | $5.01 | +1.0% | -0.2% | +1.8% | -11.7% | -6.5% | +0.5% |
| Nov 7 | BTIG | Maintains | Buy → Buy | — | $6.00 | $6.18 | +3.0% | -17.3% | -0.2% | +1.8% | -11.7% | -6.5% |
| Sep 30 | BTIG | Maintains | Buy → Buy | — | $8.77 | $8.76 | -0.1% | -3.5% | -5.1% | -1.7% | +4.3% | +0.2% |
| Sep 24 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $8.39 | $8.49 | +1.2% | +14.5% | -7.2% | +0.3% | -2.0% | -3.5% |
| Sep 9 | BTIG | Maintains | Buy → Buy | — | $9.67 | $9.82 | +1.6% | +3.3% | -8.0% | +1.3% | -3.1% | -4.4% |
| Sep 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.67 | $9.82 | +1.6% | +3.3% | -8.0% | +1.3% | -3.1% | -4.4% |
| Aug 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.62 | $9.91 | +3.0% | +0.2% | +0.1% | -0.4% | -0.3% | -0.9% |
| Jul 17 | Truist | Maintains | Buy → Buy | — | $11.44 | $11.71 | +2.4% | -1.5% | -15.4% | +2.4% | +0.1% | +4.5% |
| Jun 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $8.65 | $8.89 | +2.8% | +6.9% | +13.5% | +1.1% | +0.8% | +0.4% |
| May 13 | Needham | Maintains | Buy → Buy | — | $9.31 | $9.22 | -1.0% | -0.4% | -3.6% | -1.3% | +0.1% | -2.4% |
| May 9 | UBS | Maintains | Buy → Buy | — | $10.78 | $11.20 | +3.9% | -16.0% | +2.9% | -0.4% | -3.6% | -1.3% |
| Apr 28 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $8.98 | $9.04 | +0.7% | +4.0% | +5.4% | +0.2% | +0.9% | +7.4% |
| Apr 10 | Truist | Maintains | Buy → Buy | — | $10.00 | $9.83 | -1.7% | -1.1% | +1.4% | -2.4% | -5.1% | -0.6% |
| Mar 10 | JP Morgan | Maintains | Overweight → Overweight | — | $8.99 | $9.49 | +5.6% | +1.2% | +3.2% | +1.0% | +0.6% | -1.4% |
| Feb 24 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $10.43 | $10.44 | +0.1% | -2.4% | +2.8% | -9.7% | -8.1% | +3.6% |
| Feb 21 | Needham | Maintains | Buy → Buy | — | $10.71 | $10.69 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% |
| Feb 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.71 | $10.69 | -0.2% | -2.6% | -2.4% | +2.8% | -9.7% | -8.1% |
| Feb 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $9.97 | $10.02 | +0.5% | +0.5% | +1.0% | +4.0% | +1.8% | -2.6% |
| Feb 12 | Needham | Maintains | Buy → Buy | — | $9.86 | $9.66 | -2.0% | -2.6% | +3.9% | +0.5% | +1.0% | +4.0% |
| Jan 28 | JP Morgan | Maintains | Overweight → Overweight | — | $9.98 | $10.04 | +0.6% | +4.4% | -0.1% | +1.6% | -1.2% | -2.3% |
| Jan 24 | Oppenheimer | Maintains | Outperform → Outperform | — | $10.18 | $9.97 | -2.1% | -0.8% | -1.2% | +4.4% | -0.1% | +1.6% |
| Jan 24 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.18 | $9.97 | -2.1% | -0.8% | -1.2% | +4.4% | -0.1% | +1.6% |
| Jan 23 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.00 | $10.04 | +0.4% | +1.8% | -0.8% | -1.2% | +4.4% | -0.1% |
| Jan 22 | Truist | Maintains | Buy → Buy | — | $10.17 | $10.10 | -0.7% | -1.7% | +1.8% | -0.8% | -1.2% | +4.4% |
| Jan 21 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $10.00 | $10.04 | +0.4% | +1.7% | -1.7% | +1.8% | -0.8% | -1.2% |
| Jan 16 | UBS | Maintains | Buy → Buy | — | $9.97 | $9.96 | -0.1% | +1.9% | -1.6% | +1.7% | -1.7% | +1.8% |
| Jan 15 | Needham | Maintains | Buy → Buy | — | $11.18 | $11.40 | +2.0% | -10.8% | +1.9% | -1.6% | +1.7% | -1.7% |
| Jan 14 | RBC Capital | Maintains | Outperform → Outperform | — | $12.39 | $12.70 | +2.5% | -9.8% | -10.8% | +1.9% | -1.6% | +1.7% |
| Jan 13 | Truist | Maintains | Buy → Buy | — | $12.54 | $12.40 | -1.1% | -1.2% | -9.8% | -10.8% | +1.9% | -1.6% |
| Jan 10 | Citigroup | Maintains | Buy → Buy | — | $12.60 | $12.41 | -1.5% | -0.5% | -1.2% | -9.8% | -10.8% | +1.9% |
| Jan 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $12.60 | $12.41 | -1.5% | -0.5% | -1.2% | -9.8% | -10.8% | +1.9% |
| Nov 22 | JP Morgan | Maintains | Overweight → Overweight | — | $11.59 | $11.61 | +0.2% | -2.9% | +8.5% | +8.6% | -2.5% | -0.1% |
| Nov 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $12.38 | $12.26 | -1.0% | -0.2% | -3.2% | -5.4% | +2.5% | -2.9% |
| Nov 13 | Citigroup | Maintains | Buy → Buy | — | $14.44 | $14.53 | +0.6% | -11.7% | -0.6% | -2.3% | -0.2% | -3.2% |
No insider trades available.
8-K · 2.02
!! High
Evolent Health, Inc. -- 8-K 2.02: Earnings Results
Evolent Health reported Q1 2026 earnings results on May 7, 2026, which investors can review in the attached press release for details on operational performance and financial condition.
May 7
8-K
Evolent Health, Inc -- 8-K Filing
Evolent Health reported Q4 2025 results, showing the company's performance in managing complex healthcare conditions through its simplified care delivery model.
Feb 24
Data updated apr 25, 2026 7:59am
· Source: massive.com